These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3400265

  • 21. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW, Van Graft M, Vermeulen NP, Breimer DD.
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [Abstract] [Full Text] [Related]

  • 22. Responses of Fasciola hepatica infected sheep to various infection levels.
    Chauvin A, Moreau E, Boulard C.
    Vet Res; 2001 Aug; 32(1):87-92. PubMed ID: 11254181
    [Abstract] [Full Text] [Related]

  • 23. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL, Crom WR, Karlson KH, Mallory GB, Evans WE.
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of cytochrome P-450 mediated metabolism of antipyrine in the rat at different extents of fluosol-DA hemodilution.
    Shrewsbury RP, White LG.
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):411-4. PubMed ID: 2343186
    [Abstract] [Full Text] [Related]

  • 25. Effect of Haemonchus contortus infection on the clearance of antipyrine, sulfobromophthalein, chloramphenicol, and sulfathiazole in lambs.
    Kawalek JC, Fetterer RH.
    Am J Vet Res; 1990 Dec; 51(12):2044-9. PubMed ID: 2085232
    [Abstract] [Full Text] [Related]

  • 26. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A, Aarons L, Houston JB.
    Drug Metab Dispos; 1987 Dec; 15(1):127-32. PubMed ID: 2881749
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S, Nielsen AJ, Borg BE, Poulsen HE.
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [Abstract] [Full Text] [Related]

  • 29. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K, Breimer DD, van Bezooijen CF.
    Drug Metab Dispos; 1992 Jan; 20(4):502-6. PubMed ID: 1356725
    [Abstract] [Full Text] [Related]

  • 30. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats.
    Anadón A, Martínez MA, Martínez M, Castellano V, Ares I, Romero A, Fernández R, Martínez-Larrañaga MR.
    Toxicol Lett; 2013 Jul 04; 220(2):135-42. PubMed ID: 23639246
    [Abstract] [Full Text] [Related]

  • 31. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D, Miguet JP, Camelot G, Delafin C, Joanne C, Bechtel P, Gillet M, Carayon P.
    Gastroenterology; 1981 Jan 04; 80(1):112-8. PubMed ID: 7450397
    [Abstract] [Full Text] [Related]

  • 32. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
    Alvarez LI, Solana HD, Mottier ML, Virkel GL, Fairweather I, Lanusse CE.
    Parasitology; 2005 Oct 04; 131(Pt 4):501-10. PubMed ID: 16174415
    [Abstract] [Full Text] [Related]

  • 33. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
    Shaw PN, Hall ST, Houston JB.
    Xenobiotica; 1986 Dec 04; 16(12):1109-16. PubMed ID: 3798958
    [Abstract] [Full Text] [Related]

  • 34. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D, Blevins R, Kerner N, Rubenfire M, Edwards DJ.
    Br J Clin Pharmacol; 1986 Jun 04; 21(6):655-9. PubMed ID: 3741715
    [Abstract] [Full Text] [Related]

  • 35. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica.
    Calléja C, Bigot K, Eeckhoutte C, Sibille P, Boulard C, Galtier P.
    Int J Parasitol; 2000 Jul 04; 30(8):953-8. PubMed ID: 10927086
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis.
    Burrows GE, Tasler J, Boray JC, Egerton J.
    Res Vet Sci; 1992 Sep 04; 53(2):191-7. PubMed ID: 1439209
    [Abstract] [Full Text] [Related]

  • 39. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F, Almar M, Pozuelo M, Sansegundo D, González-Sastre M, González-Gallego J.
    J Gerontol A Biol Sci Med Sci; 1998 Jan 04; 53(1):M14-9. PubMed ID: 9467428
    [Abstract] [Full Text] [Related]

  • 40. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG, Bayon JE, González-Gallego J.
    J Sports Med Phys Fitness; 1999 Sep 04; 39(3):197-201. PubMed ID: 10573660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.